시장보고서
상품코드
1813577

세계의 트렘피어(Tremfya) 시장 분석과 예측(-2034년) : 유형, 제품, 기술, 용도, 최종사용자, 성분, 전개, 프로세스, 기능, 기구

Tremfya Market Analysis and Forecast to 2034: Type, Product, Technology, Application, End User, Component, Deployment, Process, Functionality, Equipment

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 399 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 트렘피어 시장 규모는 2024년 38억 달러에서 2034년 75억 달러로 약 7.1%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 트렘피어 시장은 중등도에서 중증의 심상성 건선 및 관절염성 건선 생물학적 제제인 트렘피어의 상업적 전망과 관련이 있습니다. 이 시장에는 제약회사, 의료 서비스 제공업체, 규제 기관이 포함됩니다. 자가면역질환의 유병률 증가와 생물학적 치료법의 발전이 시장 성장을 가속하고 있습니다. 환자 결과와 비용 효율성을 중시하는 것이 이 분야의 혁신과 경쟁의 원동력이 되고 있습니다.

트렘피어 시장은 피부과 영역의 혁신적인 생물학적 제제에 대한 수요 증가에 힘입어 강력한 성장세를 보이고 있습니다. 치료 부문에서는 심상성 건선 치료제가 압도적인 우위를 점하고 있으며, 그 효과와 환자 선호도를 보여주고 있습니다. 관절염 건선 치료는 인지도와 진단율 증가에 힘입어 그 뒤를 잇고 있습니다. 투여 방법 부문에서는 피하주사가 편의성과 환자 순응도 향상을 가져와 선두를 달리고 있습니다. 정맥주사 요법은 특히 면밀한 모니터링이 필수적인 병원 환경에서 많은 지지를 받고 있습니다. 병용요법은 다양한 환자들의 요구에 부응하고 치료 결과를 개선하는 유익한 하위 부문으로 부상하고 있습니다. 유전자 프로파일링과 표적 치료의 발전을 반영하여 맞춤형 의료 접근법도 탄력을 받고 있습니다. 환자 중심 치료 모델로의 전환은 종합적인 질병 관리에서 트렘피어의 역할을 명확히 하고, 트렘피어의 채택을 더욱 촉진하고 있습니다. 지속적인 연구 개발 노력은 치료 전망을 계속 확대하여 생물학적 제제 시장의 성장과 혁신의 새로운 기회를 약속하고 있습니다.

시장 세분화
유형 생물학적 제제, 바이오시밀러, 저분자 제제
제품 주사제, 경구제, 국소 외용제
기술 단클론항체, 재조합 DNA, 융합 단백질
용도 건선, 건선성 관절염, 기타 자가면역질환
최종사용자 병원, 클리닉, 연구기관, 재택의료
성분 원료의약품(API), 부형제, 안정제
전개 입원 환자, 외래 환자
프로세스 제조, 포장, 유통
기능 치료, 예방, 진단
기구 시린지, 바이알, 오토인젝터

시장 현황

트렘피어 시장은 생물학적 제제 부문에서의 견고한 점유율이 특징이며, 경쟁력 있는 가격 전략이 그 매력을 더하고 있습니다. 혁신적인 제형과 전략적 시장 진입을 반영하여 최근 제품 출시가 그 입지를 강화하고 있습니다. 이 브랜드의 가격 설정은 시장 수요에 전략적으로 부합하며, 수익성을 유지하면서 접근성을 보장하고 있습니다. 이러한 접근 방식을 통해 특히 신흥 시장에 중점을 두면서 다양한 지역에서 강력한 발판을 마련하고 있습니다. 경쟁 상황에서 트렘피어는 기존 생물학적 제제 및 신흥 바이오시밀러로부터 큰 적대감에 직면해 있습니다. 주요 경쟁사들은 첨단 기술 및 전략적 파트너십을 활용하여 시장에서의 입지를 강화하고 있습니다. 특히 북미와 유럽의 규제 영향은 시장 역학을 형성하는 데 중요한 역할을 하고 있습니다. 이러한 규제는 품질과 안전을 보장하고 시장 진출 전략에 영향을 미칩니다. 시장은 여전히 역동적이며, 규제 변화는 향후 성장 궤도에 영향을 미칠 것으로 예측됩니다. 지속적인 혁신과 전략적 제휴는 이러한 경쟁과 규제 문제를 극복하는 데 있어 매우 중요합니다.

주요 동향과 촉진요인:

트렘피어 시장은 건선 및 건선성 관절염의 전 세계 유병률 증가에 힘입어 성장세를 보이고 있습니다. 생물학적 제제에 대한 환자와 의료 전문가들의 인식이 높아진 것도 수요를 촉진하고 있습니다. 주요 트렌드는 치료 효과와 환자 예후를 향상시키는 맞춤형 의료로의 전환입니다. 이러한 추세는 유전체 연구와 진단 기술의 발전이 뒷받침하고 있습니다. 또한, 적응증 확대에 대한 규제 당국의 승인으로 트렘피어의 새로운 치료 영역이 열리고 있습니다. 시장은 또한 안전성 프로파일을 개선한 차세대 생물학적 제제 개발을 위한 연구개발에 대한 투자도 증가하고 있습니다. 또 다른 중요한 촉진요인은 의료 인프라가 개선되고 있는 신흥 시장에서 생물학적 제제가 받아들여지고 있다는 점입니다. 이들 지역은 시장 확대의 기회가 될 수 있습니다. 제약 기업 간의 전략적 제휴는 기술 혁신과 시장 침투를 가속화하고 있습니다. 또한, 환자 지원 프로그램은 치료 순응도를 높여 시장 성장을 더욱 촉진하고 있습니다. 의료 시스템이 계속 진화하는 가운데, 이러한 역동적인 트렌드와 촉진요인으로 인해 트렘피어 시장은 지속적으로 확대될 것으로 예측됩니다.

억제요인과 과제:

트렘피어 시장에는 몇 가지 중요한 억제요인과 과제가 있습니다. 가장 큰 문제점은 트레미아 치료와 관련된 높은 비용으로, 이는 환자의 접근성을 제한하고 의료 예산을 압박할 수 있습니다. 이러한 경제적 장벽은 의료 자금이 제한된 지역에서 특히 두드러지며, 비용 효율성이 중요한 고려사항이 됩니다. 또한, 엄격한 규제 환경과 긴 승인 절차는 시장 진입과 확장을 지연시킬 수 있습니다. 이러한 복잡한 규제를 극복하기 위해서는 상당한 자원과 전문 지식이 필요하며, 이는 기업에게 큰 부담으로 작용합니다. 시장은 또한 대체 치료 및 신흥 치료와의 경쟁에 직면해 있습니다. 이러한 대체 요법은 유사한 효과를 잠재적으로 더 낮은 비용으로 제공할 수 있기 때문에 환자와 의료 서비스 제공업체를 끌어들이고 있습니다. 또한, 환자의 트레미비아 치료 요법에 대한 순응도가 일관되지 않을 수 있으며, 이는 장기적인 결과와 시장 침투에 영향을 미칠 수 있습니다. 효과적인 교육 및 지원 프로그램을 통해 환자의 순응도를 확보하는 것이 필수적입니다. 마지막으로, 진화하는 환자의 니즈와 경쟁의 압력에 대응하기 위한 지속적인 기술 혁신의 필요성은 연구개발에 대한 막대한 투자를 요구하고 있으며, 이는 시장 기업에게 재정적 도전이 되고 있습니다.

주요 기업

Almirall, Dermira, Arcutis Biotherapeutics, UCB, Leo Pharma, Incyte, Sun Pharma, Eli Lilly and Company, Helsinn Healthcare, Maruho, Bausch Health, Kyowa Kirin, Galderma, Medimetriks Pharmaceuticals, Glenmark Pharmaceuticals

목차

제1장 트렘피어 시장 개요

  • 조사 목적
  • 트렘피어 시장 정의와 조사 범위
  • 보고서 제한
  • 조사 대상 연도와 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 주요 인사이트

제4장 트렘피어 시장 전망

  • 트렘피어 시장 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 트렘피어 시장 전략

  • 상부 시장 분석
  • 수급 분석
  • 소비자 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 트렘피어 시장 규모

  • 트렘피어 시장 규모 : 금액별
  • 트렘피어 시장 규모 : 수량별

제7장 트렘피어 시장 : 유형별

  • 시장 개요
  • 생물학적 제제
  • 바이오시밀러
  • 저분자 제제
  • 기타

제8장 트렘피어 시장 : 제품별

  • 시장 개요
  • 주사제
  • 경구제
  • 국소 외용제
  • 기타

제9장 트렘피어 시장 : 기술별

  • 시장 개요
  • 단클론항체
  • 재조합 DNA
  • 융합 단백질
  • 기타

제10장 트렘피어 시장 : 용도별

  • 시장 개요
  • 건선
  • 건선성 관절염
  • 기타 자가면역질환
  • 기타

제11장 트렘피어 시장 : 최종사용자별

  • 시장 개요
  • 병원
  • 클리닉
  • 연구기관
  • 재택의료
  • 기타

제12장 트렘피어 시장 : 성분별

  • 시장 개요
  • 원료의약품(API)
  • 부형제
  • 안정제
  • 기타

제13장 트렘피어 시장 : 전개별

  • 시장 개요
  • 입원 환자
  • 외래 환자
  • 기타

제14장 트렘피어 시장 : 프로세스별

  • 시장 개요
  • 제조
  • 포장
  • 유통
  • 기타

제15장 트렘피어 시장 : 기능별

  • 시장 개요
  • 치료
  • 예방
  • 진단
  • 기타

제16장 트렘피어 시장 : 기구별

  • 시장 개요
  • 시린지
  • 바이알
  • 오토인젝터
  • 기타

제17장 트렘피어 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트
    • 남아프리카공화국
    • 기타 중동 및 아프리카

제18장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략 벤치마킹

제19장 기업 개요

  • Almirall
  • Dermira
  • Arcutis Biotherapeutics
  • UCB
  • Leo Pharma
  • Incyte
  • Sun Pharma
  • Eli Lilly and Company
  • Helsinn Healthcare
  • Maruho
  • Bausch Health
  • Kyowa Kirin
  • Galderma
  • Medimetriks Pharmaceuticals
  • Glenmark Pharmaceuticals
KSM 25.10.10

Tremfya Market is anticipated to expand from $3.8 billion in 2024 to $7.5 billion by 2034, growing at a CAGR of approximately 7.1%. The Tremfya Market pertains to the commercial landscape of Tremfya, a biologic treatment for moderate to severe plaque psoriasis and psoriatic arthritis. This market encompasses pharmaceutical companies, healthcare providers, and regulatory bodies. The increasing prevalence of autoimmune diseases and advancements in biologic therapies are propelling market growth. Emphasis on patient outcomes and cost-effectiveness is driving innovation and competitive dynamics in this sector.

The Tremfya market is experiencing robust growth, propelled by rising demand for innovative biologic solutions in dermatology. Within the therapeutic segment, plaque psoriasis treatments dominate, showcasing significant efficacy and patient preference. Psoriatic arthritis therapies follow closely, driven by increasing awareness and diagnosis rates. In the administration method segment, subcutaneous injections lead, offering convenience and improved patient compliance. Intravenous infusions are gaining traction, particularly in hospital settings where close monitoring is essential. Combination therapies are emerging as a lucrative sub-segment, addressing diverse patient needs and enhancing treatment outcomes. Personalized medicine approaches are also gaining momentum, reflecting advancements in genetic profiling and targeted therapies. The shift towards patient-centric care models is further encouraging the adoption of Tremfya, underscoring its role in comprehensive disease management. Ongoing research and development efforts continue to expand the therapeutic landscape, promising new opportunities for growth and innovation in the biologics market.

Market Segmentation
TypeBiologics, Biosimilars, Small Molecules
ProductInjectable, Oral, Topical
TechnologyMonoclonal Antibody, Recombinant DNA, Fusion Protein
ApplicationPsoriasis, Psoriatic Arthritis, Other Autoimmune Diseases
End UserHospitals, Clinics, Research Institutes, Homecare
ComponentActive Pharmaceutical Ingredient (API), Excipients, Stabilizers
DeploymentIn-Patient, Out-Patient
ProcessManufacturing, Packaging, Distribution
FunctionalityTherapeutic, Prophylactic, Diagnostic
EquipmentSyringes, Vials, Auto-Injectors

Market Snapshot:

The market for Tremfya is characterized by a robust share in the biologics segment, with competitive pricing strategies enhancing its appeal. Recent product launches have bolstered its position, reflecting innovative formulations and strategic market entries. The brand's pricing is strategically aligned with market demands, ensuring accessibility while maintaining profitability. This approach has facilitated a strong foothold in various regions, with a particular emphasis on emerging markets. In the competitive landscape, Tremfya faces significant rivalry from established biologics and emerging biosimilars. Key competitors are leveraging advanced technologies and strategic partnerships to enhance their market presence. Regulatory influences, particularly in North America and Europe, play a critical role in shaping market dynamics. These regulations ensure quality and safety, influencing market entry strategies. The market remains dynamic, with regulatory changes anticipated to impact future growth trajectories. Continuous innovation and strategic alliances are pivotal in navigating these competitive and regulatory challenges.

Geographical Overview:

The Tremfya market is witnessing varied growth across different regions, each presenting unique opportunities. North America remains a dominant player, driven by high healthcare spending and advancements in biologics. The region's robust healthcare infrastructure supports the widespread adoption of Tremfya, particularly in the United States. Europe follows closely, with strong regulatory frameworks and increasing awareness of biologic treatments boosting the market. In Asia Pacific, the market is expanding rapidly, propelled by rising healthcare expenditures and a growing prevalence of autoimmune diseases. Countries like China and India are emerging as key growth pockets, driven by large patient populations and improving healthcare access. Latin America and the Middle East & Africa are nascent markets with significant potential. In Latin America, increasing investments in healthcare infrastructure are notable, while the Middle East & Africa are recognizing the importance of biologic treatments in addressing chronic diseases and enhancing patient care.

Key Trends and Drivers:

The Tremfya market is experiencing growth driven by the rising prevalence of psoriasis and psoriatic arthritis globally. Increasing awareness among patients and healthcare professionals about biologic therapies is also propelling demand. A key trend is the shift towards personalized medicine, which enhances treatment efficacy and patient outcomes. This trend is supported by advances in genomic research and diagnostic technologies. Moreover, regulatory approvals for expanded indications are opening new therapeutic areas for Tremfya. The market is also seeing increased investment in R&D to develop next-generation biologics with improved safety profiles. Another significant driver is the growing acceptance of biologics in emerging markets, where healthcare infrastructure is improving. These regions present lucrative opportunities for market expansion. Strategic collaborations between pharmaceutical companies are accelerating innovation and market penetration. Additionally, patient support programs are enhancing treatment adherence, further boosting market growth. As healthcare systems continue to evolve, the Tremfya market is poised for sustained expansion, driven by these dynamic trends and drivers.

Restraints and Challenges:

The Tremfya market encounters several significant restraints and challenges. A primary challenge is the high cost associated with Tremfya treatments, which can limit accessibility for patients and strain healthcare budgets. This financial barrier is particularly pronounced in regions with limited healthcare funding, where cost-effectiveness becomes a critical consideration. Additionally, stringent regulatory environments and lengthy approval processes can delay market entry and expansion. Navigating these complex regulations requires substantial resources and expertise, which can be daunting for companies. The market also faces competition from alternative treatments and emerging therapies. These alternatives can offer similar efficacy at potentially lower costs, attracting patients and healthcare providers. Furthermore, patient adherence to Tremfya treatment regimens can be inconsistent, impacting long-term outcomes and market penetration. Ensuring patient compliance through effective education and support programs is essential. Lastly, the need for continuous innovation to address evolving patient needs and competitive pressures demands significant investment in research and development, posing a financial challenge for market players.

Key Players:

Almirall, Dermira, Arcutis Biotherapeutics, UCB, Leo Pharma, Incyte, Sun Pharma, Eli Lilly and Company, Helsinn Healthcare, Maruho, Bausch Health, Kyowa Kirin, Galderma, Medimetriks Pharmaceuticals, Glenmark Pharmaceuticals

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Tremfya Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Tremfya Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Technology
  • 2.6 Key Highlights of the Market, by Application
  • 2.7 Key Highlights of the Market, by End User
  • 2.8 Key Highlights of the Market, by Component
  • 2.9 Key Highlights of the Market, by Deployment
  • 2.10 Key Highlights of the Market, by Process
  • 2.11 Key Highlights of the Market, by Functionality
  • 2.12 Key Highlights of the Market, by Equipment
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Technology
  • 3.5 Market Attractiveness Analysis, by Application
  • 3.6 Market Attractiveness Analysis, by End User
  • 3.7 Market Attractiveness Analysis, by Component
  • 3.8 Market Attractiveness Analysis, by Deployment
  • 3.9 Market Attractiveness Analysis, by Process
  • 3.10 Market Attractiveness Analysis, by Functionality
  • 3.11 Market Attractiveness Analysis, by Equipment
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Tremfya Market Outlook

  • 4.1 Tremfya Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Tremfya Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Tremfya Market Size

  • 6.1 Tremfya Market Size, by Value
  • 6.2 Tremfya Market Size, by Volume

7: Tremfya Market, by Type

  • 7.1 Market Overview
  • 7.2 Biologics
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Biosimilars
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Small Molecules
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Others
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region

8: Tremfya Market, by Product

  • 8.1 Market Overview
  • 8.2 Injectable
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Oral
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Topical
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Others
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region

9: Tremfya Market, by Technology

  • 9.1 Market Overview
  • 9.2 Monoclonal Antibody
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Recombinant DNA
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Fusion Protein
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: Tremfya Market, by Application

  • 10.1 Market Overview
  • 10.2 Psoriasis
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Psoriatic Arthritis
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Other Autoimmune Diseases
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Others
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region

11: Tremfya Market, by End User

  • 11.1 Market Overview
  • 11.2 Hospitals
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Clinics
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Research Institutes
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Homecare
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: Tremfya Market, by Component

  • 12.1 Market Overview
  • 12.2 Active Pharmaceutical Ingredient (API)
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Excipients
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Stabilizers
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Tremfya Market, by Deployment

  • 13.1 Market Overview
  • 13.2 In-Patient
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Out-Patient
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Tremfya Market, by Process

  • 14.1 Market Overview
  • 14.2 Manufacturing
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Packaging
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Distribution
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Tremfya Market, by Functionality

  • 15.1 Market Overview
  • 15.2 Therapeutic
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Prophylactic
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Diagnostic
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Tremfya Market, by Equipment

  • 16.1 Market Overview
  • 16.2 Syringes
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Vials
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Auto-Injectors
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Others
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region

17: Tremfya Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Technology
    • 17.2.5 North America Market Size and Forecast, by Application
    • 17.2.6 North America Market Size and Forecast, by End User
    • 17.2.7 North America Market Size and Forecast, by Component
    • 17.2.8 North America Market Size and Forecast, by Deployment
    • 17.2.9 North America Market Size and Forecast, by Process
    • 17.2.10 North America Market Size and Forecast, by Functionality
    • 17.2.11 North America Market Size and Forecast, by Equipment
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Technology
      • 17.2.9.4 United States Market Size and Forecast, by Application
      • 17.2.9.5 United States Market Size and Forecast, by End User
      • 17.2.9.6 United States Market Size and Forecast, by Component
      • 17.2.9.7 United States Market Size and Forecast, by Deployment
      • 17.2.9.8 United States Market Size and Forecast, by Process
      • 17.2.9.9 United States Market Size and Forecast, by Functionality
      • 17.2.9.10 United States Market Size and Forecast, by Equipment
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Technology
      • 17.2.10.4 Canada Market Size and Forecast, by Application
      • 17.2.10.5 Canada Market Size and Forecast, by End User
      • 17.2.10.6 Canada Market Size and Forecast, by Component
      • 17.2.10.7 Canada Market Size and Forecast, by Deployment
      • 17.2.10.8 Canada Market Size and Forecast, by Process
      • 17.2.10.9 Canada Market Size and Forecast, by Functionality
      • 17.2.10.10 Canada Market Size and Forecast, by Equipment
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Technology
    • 17.3.5 Europe Market Size and Forecast, by Application
    • 17.3.6 Europe Market Size and Forecast, by End User
    • 17.3.7 Europe Market Size and Forecast, by Component
    • 17.3.8 Europe Market Size and Forecast, by Deployment
    • 17.3.9 Europe Market Size and Forecast, by Process
    • 17.3.10 Europe Market Size and Forecast, by Functionality
    • 17.3.11 Europe Market Size and Forecast, by Equipment
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.5 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Component
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Deployment
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Functionality
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Equipment
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Technology
      • 17.3.10.4 Germany Market Size and Forecast, by Application
      • 17.3.10.5 Germany Market Size and Forecast, by End User
      • 17.3.10.6 Germany Market Size and Forecast, by Component
      • 17.3.10.7 Germany Market Size and Forecast, by Deployment
      • 17.3.10.8 Germany Market Size and Forecast, by Process
      • 17.3.10.9 Germany Market Size and Forecast, by Functionality
      • 17.3.10.10 Germany Market Size and Forecast, by Equipment
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Technology
      • 17.3.11.4 France Market Size and Forecast, by Application
      • 17.3.11.5 France Market Size and Forecast, by End User
      • 17.3.11.6 France Market Size and Forecast, by Component
      • 17.3.11.7 France Market Size and Forecast, by Deployment
      • 17.3.11.8 France Market Size and Forecast, by Process
      • 17.3.11.9 France Market Size and Forecast, by Functionality
      • 17.3.11.10 France Market Size and Forecast, by Equipment
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Technology
      • 17.3.12.4 Spain Market Size and Forecast, by Application
      • 17.3.12.5 Spain Market Size and Forecast, by End User
      • 17.3.12.6 Spain Market Size and Forecast, by Component
      • 17.3.12.7 Spain Market Size and Forecast, by Deployment
      • 17.3.12.8 Spain Market Size and Forecast, by Process
      • 17.3.12.9 Spain Market Size and Forecast, by Functionality
      • 17.3.12.10 Spain Market Size and Forecast, by Equipment
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Technology
      • 17.3.13.4 Italy Market Size and Forecast, by Application
      • 17.3.13.5 Italy Market Size and Forecast, by End User
      • 17.3.13.6 Italy Market Size and Forecast, by Component
      • 17.3.13.7 Italy Market Size and Forecast, by Deployment
      • 17.3.13.8 Italy Market Size and Forecast, by Process
      • 17.3.13.9 Italy Market Size and Forecast, by Functionality
      • 17.3.13.10 Italy Market Size and Forecast, by Equipment
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.4 Netherlands Market Size and Forecast, by Application
      • 17.3.14.5 Netherlands Market Size and Forecast, by End User
      • 17.3.14.6 Netherlands Market Size and Forecast, by Component
      • 17.3.14.7 Netherlands Market Size and Forecast, by Deployment
      • 17.3.14.8 Netherlands Market Size and Forecast, by Process
      • 17.3.14.9 Netherlands Market Size and Forecast, by Functionality
      • 17.3.14.10 Netherlands Market Size and Forecast, by Equipment
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Technology
      • 17.3.15.4 Sweden Market Size and Forecast, by Application
      • 17.3.15.5 Sweden Market Size and Forecast, by End User
      • 17.3.15.6 Sweden Market Size and Forecast, by Component
      • 17.3.15.7 Sweden Market Size and Forecast, by Deployment
      • 17.3.15.8 Sweden Market Size and Forecast, by Process
      • 17.3.15.9 Sweden Market Size and Forecast, by Functionality
      • 17.3.15.10 Sweden Market Size and Forecast, by Equipment
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.4 Switzerland Market Size and Forecast, by Application
      • 17.3.16.5 Switzerland Market Size and Forecast, by End User
      • 17.3.16.6 Switzerland Market Size and Forecast, by Component
      • 17.3.16.7 Switzerland Market Size and Forecast, by Deployment
      • 17.3.16.8 Switzerland Market Size and Forecast, by Process
      • 17.3.16.9 Switzerland Market Size and Forecast, by Functionality
      • 17.3.16.10 Switzerland Market Size and Forecast, by Equipment
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Technology
      • 17.3.17.4 Denmark Market Size and Forecast, by Application
      • 17.3.17.5 Denmark Market Size and Forecast, by End User
      • 17.3.17.6 Denmark Market Size and Forecast, by Component
      • 17.3.17.7 Denmark Market Size and Forecast, by Deployment
      • 17.3.17.8 Denmark Market Size and Forecast, by Process
      • 17.3.17.9 Denmark Market Size and Forecast, by Functionality
      • 17.3.17.10 Denmark Market Size and Forecast, by Equipment
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Technology
      • 17.3.18.4 Finland Market Size and Forecast, by Application
      • 17.3.18.5 Finland Market Size and Forecast, by End User
      • 17.3.18.6 Finland Market Size and Forecast, by Component
      • 17.3.18.7 Finland Market Size and Forecast, by Deployment
      • 17.3.18.8 Finland Market Size and Forecast, by Process
      • 17.3.18.9 Finland Market Size and Forecast, by Functionality
      • 17.3.18.10 Finland Market Size and Forecast, by Equipment
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Technology
      • 17.3.19.4 Russia Market Size and Forecast, by Application
      • 17.3.19.5 Russia Market Size and Forecast, by End User
      • 17.3.19.6 Russia Market Size and Forecast, by Component
      • 17.3.19.7 Russia Market Size and Forecast, by Deployment
      • 17.3.19.8 Russia Market Size and Forecast, by Process
      • 17.3.19.9 Russia Market Size and Forecast, by Functionality
      • 17.3.19.10 Russia Market Size and Forecast, by Equipment
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Component
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Deployment
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Functionality
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Equipment
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.6 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Component
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Deployment
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Functionality
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Equipment
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Technology
      • 17.4.9.4 China Market Size and Forecast, by Application
      • 17.4.9.5 China Market Size and Forecast, by End User
      • 17.4.9.6 China Market Size and Forecast, by Component
      • 17.4.9.7 China Market Size and Forecast, by Deployment
      • 17.4.9.8 China Market Size and Forecast, by Process
      • 17.4.9.9 China Market Size and Forecast, by Functionality
      • 17.4.9.10 China Market Size and Forecast, by Equipment
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Technology
      • 17.4.10.4 India Market Size and Forecast, by Application
      • 17.4.10.5 India Market Size and Forecast, by End User
      • 17.4.10.6 India Market Size and Forecast, by Component
      • 17.4.10.7 India Market Size and Forecast, by Deployment
      • 17.4.10.8 India Market Size and Forecast, by Process
      • 17.4.10.9 India Market Size and Forecast, by Functionality
      • 17.4.10.10 India Market Size and Forecast, by Equipment
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Technology
      • 17.4.11.4 Japan Market Size and Forecast, by Application
      • 17.4.11.5 Japan Market Size and Forecast, by End User
      • 17.4.11.6 Japan Market Size and Forecast, by Component
      • 17.4.11.7 Japan Market Size and Forecast, by Deployment
      • 17.4.11.8 Japan Market Size and Forecast, by Process
      • 17.4.11.9 Japan Market Size and Forecast, by Functionality
      • 17.4.11.10 Japan Market Size and Forecast, by Equipment
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Technology
      • 17.4.12.4 South Korea Market Size and Forecast, by Application
      • 17.4.12.5 South Korea Market Size and Forecast, by End User
      • 17.4.12.6 South Korea Market Size and Forecast, by Component
      • 17.4.12.7 South Korea Market Size and Forecast, by Deployment
      • 17.4.12.8 South Korea Market Size and Forecast, by Process
      • 17.4.12.9 South Korea Market Size and Forecast, by Functionality
      • 17.4.12.10 South Korea Market Size and Forecast, by Equipment
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Technology
      • 17.4.13.4 Australia Market Size and Forecast, by Application
      • 17.4.13.5 Australia Market Size and Forecast, by End User
      • 17.4.13.6 Australia Market Size and Forecast, by Component
      • 17.4.13.7 Australia Market Size and Forecast, by Deployment
      • 17.4.13.8 Australia Market Size and Forecast, by Process
      • 17.4.13.9 Australia Market Size and Forecast, by Functionality
      • 17.4.13.10 Australia Market Size and Forecast, by Equipment
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Technology
      • 17.4.14.4 Singapore Market Size and Forecast, by Application
      • 17.4.14.5 Singapore Market Size and Forecast, by End User
      • 17.4.14.6 Singapore Market Size and Forecast, by Component
      • 17.4.14.7 Singapore Market Size and Forecast, by Deployment
      • 17.4.14.8 Singapore Market Size and Forecast, by Process
      • 17.4.14.9 Singapore Market Size and Forecast, by Functionality
      • 17.4.14.10 Singapore Market Size and Forecast, by Equipment
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.4 Indonesia Market Size and Forecast, by Application
      • 17.4.15.5 Indonesia Market Size and Forecast, by End User
      • 17.4.15.6 Indonesia Market Size and Forecast, by Component
      • 17.4.15.7 Indonesia Market Size and Forecast, by Deployment
      • 17.4.15.8 Indonesia Market Size and Forecast, by Process
      • 17.4.15.9 Indonesia Market Size and Forecast, by Functionality
      • 17.4.15.10 Indonesia Market Size and Forecast, by Equipment
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.4 Taiwan Market Size and Forecast, by Application
      • 17.4.16.5 Taiwan Market Size and Forecast, by End User
      • 17.4.16.6 Taiwan Market Size and Forecast, by Component
      • 17.4.16.7 Taiwan Market Size and Forecast, by Deployment
      • 17.4.16.8 Taiwan Market Size and Forecast, by Process
      • 17.4.16.9 Taiwan Market Size and Forecast, by Functionality
      • 17.4.16.10 Taiwan Market Size and Forecast, by Equipment
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.4 Malaysia Market Size and Forecast, by Application
      • 17.4.17.5 Malaysia Market Size and Forecast, by End User
      • 17.4.17.6 Malaysia Market Size and Forecast, by Component
      • 17.4.17.7 Malaysia Market Size and Forecast, by Deployment
      • 17.4.17.8 Malaysia Market Size and Forecast, by Process
      • 17.4.17.9 Malaysia Market Size and Forecast, by Functionality
      • 17.4.17.10 Malaysia Market Size and Forecast, by Equipment
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Equipment
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Technology
    • 17.5.5 Latin America Market Size and Forecast, by Application
    • 17.5.6 Latin America Market Size and Forecast, by End User
    • 17.5.7 Latin America Market Size and Forecast, by Component
    • 17.5.8 Latin America Market Size and Forecast, by Deployment
    • 17.5.9 Latin America Market Size and Forecast, by Process
    • 17.5.10 Latin America Market Size and Forecast, by Functionality
    • 17.5.11 Latin America Market Size and Forecast, by Equipment
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Technology
      • 17.5.9.4 Brazil Market Size and Forecast, by Application
      • 17.5.9.5 Brazil Market Size and Forecast, by End User
      • 17.5.9.6 Brazil Market Size and Forecast, by Component
      • 17.5.9.7 Brazil Market Size and Forecast, by Deployment
      • 17.5.9.8 Brazil Market Size and Forecast, by Process
      • 17.5.9.9 Brazil Market Size and Forecast, by Functionality
      • 17.5.9.10 Brazil Market Size and Forecast, by Equipment
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Technology
      • 17.5.10.4 Mexico Market Size and Forecast, by Application
      • 17.5.10.5 Mexico Market Size and Forecast, by End User
      • 17.5.10.6 Mexico Market Size and Forecast, by Component
      • 17.5.10.7 Mexico Market Size and Forecast, by Deployment
      • 17.5.10.8 Mexico Market Size and Forecast, by Process
      • 17.5.10.9 Mexico Market Size and Forecast, by Functionality
      • 17.5.10.10 Mexico Market Size and Forecast, by Equipment
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Technology
      • 17.5.11.4 Argentina Market Size and Forecast, by Application
      • 17.5.11.5 Argentina Market Size and Forecast, by End User
      • 17.5.11.6 Argentina Market Size and Forecast, by Component
      • 17.5.11.7 Argentina Market Size and Forecast, by Deployment
      • 17.5.11.8 Argentina Market Size and Forecast, by Process
      • 17.5.11.9 Argentina Market Size and Forecast, by Functionality
      • 17.5.11.10 Argentina Market Size and Forecast, by Equipment
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Component
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Deployment
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Functionality
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Equipment
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.6 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Component
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Deployment
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Functionality
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Equipment
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Component
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Deployment
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Functionality
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Equipment
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Technology
      • 17.6.10.4 UAE Market Size and Forecast, by Application
      • 17.6.10.5 UAE Market Size and Forecast, by End User
      • 17.6.10.6 UAE Market Size and Forecast, by Component
      • 17.6.10.7 UAE Market Size and Forecast, by Deployment
      • 17.6.10.8 UAE Market Size and Forecast, by Process
      • 17.6.10.9 UAE Market Size and Forecast, by Functionality
      • 17.6.10.10 UAE Market Size and Forecast, by Equipment
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Technology
      • 17.6.11.4 South Africa Market Size and Forecast, by Application
      • 17.6.11.5 South Africa Market Size and Forecast, by End User
      • 17.6.11.6 South Africa Market Size and Forecast, by Component
      • 17.6.11.7 South Africa Market Size and Forecast, by Deployment
      • 17.6.11.8 South Africa Market Size and Forecast, by Process
      • 17.6.11.9 South Africa Market Size and Forecast, by Functionality
      • 17.6.11.10 South Africa Market Size and Forecast, by Equipment
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Component
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Deployment
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Functionality
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Equipment
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Almirall
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Dermira
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Arcutis Biotherapeutics
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 UCB
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Leo Pharma
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Incyte
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Sun Pharma
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Eli Lilly and Company
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Helsinn Healthcare
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Maruho
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Bausch Health
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Kyowa Kirin
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Galderma
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Medimetriks Pharmaceuticals
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 Glenmark Pharmaceuticals
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제